MARKET

VLRX

VLRX

Valeritas Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.730
-0.020
-1.14%
Closed 16:00 12/13 EST
OPEN
1.750
PREV CLOSE
1.750
HIGH
1.830
LOW
1.650
VOLUME
60.76K
TURNOVER
--
52 WEEK HIGH
11.39
52 WEEK LOW
1.100
MARKET CAP
14.31M
P/E (TTM)
-0.1480
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VLRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

VLRX News

  • Valeritas Presents Positive h-Patch CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 Annual Meeting
  • GlobeNewswire.5d ago
  • Edited Transcript of VLRX earnings conference call or presentation 12-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.12/04 10:53
  • Valeritas Holdings, Inc. (VLRX): Are Hedge Funds Right About This Stock?
  • Insider Monkey.11/29 03:44
  • Valeritas up 9% premarket on additional positive V-Go data
  • Seeking Alpha - Article.11/15 14:30

More

Industry

Medical Equipment, Supplies & Distribution
+0.35%
Healthcare Equipment & Supplies
+0.24%

Hot Stocks

Name
Price
%Change

About VLRX

Valeritas Holdings, Inc. is a commercial-stage medical technology company. The Company is focused on developing technologies for Type 2 diabetes. The Company's product, the V-Go Wearable Insulin Delivery Device (V-Go), is an insulin delivery device that helps patients with Type 2 diabetes requiring insulin to maintain their target blood glucose goals. V-Go is a disposable insulin delivery device that a patient adheres to his or her skin every 24 hours. V-Go enables patients to closely mimic the body's normal physiologic pattern of insulin delivery throughout the day and to manage their diabetes with insulin without the need to plan a daily routine around multiple daily injections. The Company has developed V-Go utilizing its h-Patch platform as a patient-focused solution to address insulin therapies. Its h-Patch platform facilitates the subcutaneous delivery of injectable medicines to patients across a range of therapeutic areas.
More

Webull offers Valeritas Holdings Inc (VLRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.